Sernova Biotherapeutics Inc Stock Price

TSX:SVA Community·CA$43.8m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
14 Fair Values set on narratives written by author

Create a narrative

SVA Share Price Performance

CA$0.13

-0.10 (-42.22%)

CA$0.13

-0.10 (-42.22%)

CA$0.13

Sat, 27 Dec 25

Share Pricen/a

SVA Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Exceptional growth potential with low risk.

3 Risks

1 Reward

View Full Analysis

Sernova Biotherapeutics Inc Key Details

Last Reported Earnings

Oct 31, 2025

Next Reporting Earnings

n/a

: -0.047
: 0%
: 0%
: -19.0%

View Full Analysis

About SVA

Founded: n/a
Employees: 8
CEO: Jonathan M. Rigby
WebsiteView website: www.sernova.com

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada.